Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Cash from Operations (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Cash from Operations readings, the most recent being 11699000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 30.37% to 11699000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 14170000.0, a 79.92% increase, with the full-year FY2025 number at 19272000.0, up 75.53% from a year prior.
  • Cash from Operations hit 11699000.0 in Q4 2025 for Enanta Pharmaceuticals, down from 6489000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 17506000.0 in Q2 2025 to a low of 35641000.0 in Q4 2022.
  • Median Cash from Operations over the past 5 years was 16167500.0 (2022), compared with a mean of 17638850.0.
  • Biggest five-year swings in Cash from Operations: plummeted 557.44% in 2021 and later skyrocketed 218.48% in 2025.
  • Enanta Pharmaceuticals' Cash from Operations stood at 13271000.0 in 2021, then crashed by 168.56% to 35641000.0 in 2022, then increased by 29.89% to 24988000.0 in 2023, then soared by 32.76% to 16801000.0 in 2024, then surged by 30.37% to 11699000.0 in 2025.
  • The last three reported values for Cash from Operations were 11699000.0 (Q4 2025), 6489000.0 (Q3 2025), and 17506000.0 (Q2 2025) per Business Quant data.